| Autor: |
Liu Xiao-Jiao, Zhang Lin-Jie, Yi Ming, Li Li-Min, Wang Jing, Qi Yuan, Zhao Peng, Zhang Da-Qi, Yang Li |
| Jazyk: |
angličtina |
| Rok vydání: |
2020 |
| Předmět: |
|
| Zdroj: |
Translational Neuroscience, Vol 11, Iss 1, Pp 302-308 (2020) |
| Druh dokumentu: |
article |
| ISSN: |
2081-6936 |
| DOI: |
10.1515/tnsci-2020-0134 |
| Popis: |
Interleukin-27 (IL-27), which belongs to IL-12 family, influences the function of T cells (Tregs) through regulating the expression, and function of forkhead box P3 (FoxP3). In this study, we detected the IL-27 serum levels in 59 myasthenia gravis (MG) patients and 35 healthy controls (HCs). Among them, 32 MG patients received immunoglobulin intravenous (IVIG) injections (0.4 g/kg per day for 5 consecutive days). IL-27 levels were collected before and after the treatments and subjected to a comparative study. Finally, we assessed the correlations of IL-27 levels with the clinical characteristics of MG. As a result, serum IL-27 levels were significantly higher in MG patients than those in the HCs. Meanwhile, significant reduction was detected after the IVIG treatment. IL-27 levels positively correlated with both MG activities of daily living and quantitative MG score. IL-27 may participate in the pathogenesis of MG and can be used as an early marker for the diagnosis and prognosis of MG. In addition, IL-27 can be used as a target for MG treatment through the regulation of specific immune signaling and maintaining immune homeostasis. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
